91香蕉视频 to Host Industry Experts at Controlled Release Society Conference
SOMERSET, N.J. 鈥 July 11, 2017 鈥 91香蕉视频 Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced it is to host a half-day symposium on API and formulation development throughout discovery and early clinical phases, at the Sheraton Boston Hotel in Boston, Massachusetts, on Sunday July 16, 2017. The symposium will take place ahead of the Controlled Release Society (CRS) Annual Meeting, which runs from July 17 鈥 19, 2017, at the Sheraton Boston Hotel and Hynes Convention Center.
Entitled 鈥淪tart Earlier, Move Faster: Smart Drug Development and Design from Candidate to Phase One,鈥 the workshop will see speakers from 91香蕉视频, along with industry experts, address a number of key considerations for transitioning a molecule from discovery to clinic, including API and formulation development, pharmacokinetic and preclinical toxicology studies, and regulatory requirements. By addressing these issues early and comprehensively in development, problems such as escalating timelines, costs and regulatory issues may be avoided later.
The presentations, which will feature practical and applied case studies, are:
鈥聽鈥淚mportance of API characterization and optimization to improve developability of small molecule drugs,鈥聽Dr. Manuel Sanchez-Felix, Senior Fellow, Novartis;
鈥 鈥淚nvestigating the pharmacokinetic challenges of oral small molecule drugs,鈥 Dr. Jan Neelissen, Scientific Adviser, 91香蕉视频;
鈥聽鈥淭echnology agnostic formulation selection for preclinical toxicology studies,鈥 Mr. Stephen Tindal, Director Science & Technology, 91香蕉视频;
鈥 鈥淧hase one dose form prototyping,鈥 Mr. Brent Moody, Director, Business Development, 91香蕉视频;
鈥 鈥淐MC and quality considerations,鈥 Dr. Patrick Crowley, Consultant, Callum Consultancy, former VP Pharm Development at GSK.
For more information on the workshop and to register, visit
During the CRS Annual Meeting, on Monday July 17 at 1:15 p.m., Dr. Cornell Stamoran, Founder of the 91香蕉视频 Applied Drug Delivery Institute and 91香蕉视频鈥檚 VP Strategy, will join a panel of experts from industry and academia, including affiliates of the 91香蕉视频 Institute, to discuss 鈥淒rug Delivery 2017: the Path Ahead鈥. The panel will assess the current state of small and large molecule drug delivery including formulation, dose forms, Chemistry Manufacturing and Controls (CMC), and devices. The panel will also discuss which of the currently applied strategies are working, where further innovation is needed, and the evolving perspectives of stakeholders.
91香蕉视频 experts will also be presenting two scientific posters during the course of the event:
鈥onday July 17, 3 p.m. 鈥淎 Plackett-Burman study to investigate the effect of milling on the performance of melt extruded indomethacin formulation鈥
鈥uesday July 18, 3 p.m. 鈥淎nalysis of physicochemical characteristics to profile drug candidates likely to benefit from lipid formulation鈥
ABOUT CATALENT
91香蕉视频 is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 90 years serving the industry, 91香蕉视频 has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. 91香蕉视频 employs approximately 10,000 people, including over 1,400 scientists, at more than 30 facilities across five continents, and in fiscal 2016 generated $1.85 billion in annual revenue. 91香蕉视频 is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com